Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Yoon-Koo KangTae Won Kim

Abstract

To determine whether concurrent pyridoxine therapy can prevent the development of hand-foot syndrome (HFS) in patients being treated with capecitabine. Chemotherapy-naive patients with GI tract cancers scheduled for capecitabine-containing chemotherapy were randomly assigned to concurrent oral pyridoxine (200 mg/d) or placebo. Patients were stratified by chemotherapy regimen and monitored until development of National Cancer Institute Common Toxicity Criteria grade 2 or worse HFS or capecitabine-containing chemotherapy ended. Patients in the placebo group who developed grade 2 or worse HFS were randomly assigned again to receive pyridoxine or placebo in the next chemotherapy cycle to determine whether pyridoxine could improve HFS. The median number of chemotherapy cycles to grade 2 or worse HFS was three in both groups. Grade 2 or worse HFS developed in 55 (30.6%) of 180 placebo-treated patients and in 57 (31.7%) of 180 pyridoxine patients. The cumulative dose of capecitabine to grade 2 or worse HFS was not different between the two groups (median not reached in either group; hazard ratio [HR] = 0.95; P = .788). Randomization of the 44 patients in the placebo group with grade 2 or worse HFS to placebo or pyridoxine for the next...Continue Reading

References

Jun 1, 1991·Journal of the American Academy of Dermatology·J BrownC Collins
Mar 1, 1991·Journal of the American Academy of Dermatology·B R Baack, W H Burgdorf
Oct 15, 1989·Annals of Internal Medicine·S J VukeljaR B Weiss
Dec 1, 1984·Annals of Internal Medicine·J J Lokich, C Moore
Feb 1, 1995·Archives of Dermatology·G C ZimmermanD D Von Hoff
Sep 1, 1993·Journal of the National Cancer Institute·S J VukeljaD Von Hoff
Jan 1, 1994·Cancer Chemotherapy and Pharmacology·I PortalX Garcia-del-Muro
Nov 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Meta-Analysis Group In CancerP Thirion
May 3, 2000·The British Journal of Dermatology·C Y ChuH C Chiu
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·T IkedaM Yoshimoto
Nov 27, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C H SmorenburgJ Verweij
Jun 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Padma NadellaMiguel A Villalona-Calero
Dec 13, 2002·American Journal of Clinical Oncology·Dorothee EichThomas Krieg
Sep 3, 2004·Journal of Clinical Pharmacology·Young Seol HeoYoon-Koo Kang
Sep 29, 2005·The Breast : Official Journal of the European Society of Mastology·Ismail Oguz KaraM Erkisi
Jan 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jane L Yen-RevolloHoward L McLeod
Mar 18, 2008·British Journal of Clinical Pharmacology·Gérard MilanoPaul Hofman

❮ Previous
Next ❯

Citations

May 21, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ming J PoiRobert Wesolowski
Sep 27, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H J SchmollA Cervantes
Jan 9, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Justin M JuliusJudith A Smith
Aug 30, 2011·Current Oncology·M MackenzieD Jonker
Jan 28, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lígia Traldi MacedoAndre Deeke Sasse
May 6, 2014·Journal of the American Academy of Dermatology·Kristen K MillerBeth N McLellan
Jun 9, 2014·Cancer Chemotherapy and Pharmacology·Bingnan ZhangNikolai Podoltsev
Oct 17, 2015·Expert Review of Gastroenterology & Hepatology·Tae-Yong KimYung-Jue Bang
Dec 23, 2010·Expert Opinion on Drug Safety·Muhammad Wasif Saif
Jul 19, 2011·Clinical Colorectal Cancer·Livia Almeida da CruzRachel Simões Pimenta Riechelmann
Mar 25, 2014·The Breast : Official Journal of the European Society of Mastology·Arnoud J TempletonUNKNOWN Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center
Oct 25, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kellen L MeadowsHerbert I Hurwitz
Jan 17, 2015·Journal of the American Academy of Dermatology·James B MacdonaldAleksandar Sekulic
May 26, 2016·American Journal of Clinical Dermatology·Kumutnart ChanprapaphVasanop Vachiramon
Oct 11, 2016·Expert Opinion on Drug Safety·V NikolaouM W Saif
Jul 1, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ralf-Dieter HofheinzAndreas Schneeweiss
Mar 13, 2013·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Christy S HarrisAlison Carulli
Jan 23, 2018·International Journal of Cancer. Journal International Du Cancer·Xuan-Zhang HuangJian Wu
Jun 8, 2011·Nature Reviews. Gastroenterology & Hepatology·Lorenzo FornaroAlfredo Falcone
Mar 24, 2018·F1000Research·Rashmi Advani, Danit Arad
Feb 8, 2011·Current Treatment Options in Oncology·Deepa Reddy, Zev A Wainberg
Dec 1, 2011·Surgery Today·Takashi Oshima, Munetaka Masuda
Dec 4, 2012·Indian Journal of Surgical Oncology·Vikram K JainSheela Rao
Aug 5, 2011·Drugs·Jaclyn YoongTrevor Leong
Aug 16, 2011·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Kohei ShitaraKeitaro Matsuo
Feb 14, 2020·British Journal of Nursing : BJN·Sarah McCauleyKatherine Ma Rogers
May 15, 2020·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Kazuteru WatanabeItaru Endo
Nov 26, 2011·Expert Review of Anticancer Therapy·Davendra P S Sohal, Weijing Sun
Mar 2, 2012·Expert Review of Gastroenterology & Hepatology·Timothy J PriceNiall C Tebbutt
Jul 9, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Diva SilvaIsabel F Almeida
Nov 3, 2017·Journal of Dietary Supplements·Vanessa Armenio ScontreAuro Del Giglio
Aug 25, 2020·Oncology Nursing Forum·Loretta A WilliamsRebecca L Morgan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.